SEI Investments
PHAT icon

SEI Investments’s Phathom Pharmaceuticals PHAT Stock Holding History

SEI Investments’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33,898
Closed -$613K – 2776
2024
Q3 		$613K Buy
+33,898
New +$474K ﹤0.01% 2112
2023
Q1 		– Sell
-58,585
Closed -$657K – 2723
2022
Q4 		$657K Sell
58,585
-1,004
-2% -$10.3K ﹤0.01% 1913
2022
Q3 		$660K Sell
59,589
-4,110
-6% -$39.2K ﹤0.01% 1969
2022
Q2 		$538K Sell
63,699
-2,942
-4% -$30.2K ﹤0.01% 2071
2022
Q1 		$907K Buy
66,641
+7,978
+14% +$129K ﹤0.01% 1849
2021
Q4 		$1.15M Buy
58,663
+15,719
+37% +$370K ﹤0.01% 1791
2021
Q3 		$1.38M Buy
42,944
+3,516
+9% +$117K ﹤0.01% 1653
2021
Q2 		$1.33M Buy
+39,428
New +$1.41M ﹤0.01% 1682

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

SEI Investments's PHAT Position: Q4 2024 in Review

SEI Investments sold out of Phathom Pharmaceuticals (PHAT) in Q4 2024, closing a stake of 33,898 shares — an estimated $613K sold.

SEI Investments first reported a position in PHAT in Q2 2021 and held it in 8 quarters. The position peaked at $1.38M in Q3 2021. 144 funds tracked by Wall St. Rank hold PHAT as of Q4 2024.

  • SEI Investments reported no remaining Phathom Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • SEI Investments sold 33,898 Phathom Pharmaceuticals shares in Q4 2024, an estimated $613K.
  • SEI Investments first reported a position in Phathom Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • SEI Investments's Phathom Pharmaceuticals position peaked at $1.38M in Q3 2021.
  • 144 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q4 2024.

Based on SEI Investments's 13F filing for Q4 2024, filed 11 Feb 2025.